Cara Common Stock Total Equity from 2010 to 2024
| CARA Stock | USD 0.81 0.05 6.58% |
Common Stock Total Equity | First Reported 2012-12-31 | Previous Quarter 54 K | Current Value 54 K | Quarterly Volatility 13.7 K |
Check Cara Therapeutic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cara main balance sheet or income statement drivers, such as Depreciation And Amortization of 498.1 K, Interest Expense of 1 M or Selling General Administrative of 15.7 M, as well as many exotic indicators such as Price To Sales Ratio of 1.82, Dividend Yield of 0.0 or PTB Ratio of 0.67. Cara financial statements analysis is a perfect complement when working with Cara Therapeutic Valuation or Volatility modules.
Cara | Common Stock Total Equity |
Latest Cara Therapeutic's Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of Cara Therapeutic over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Cara Therapeutic's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cara Therapeutic's overall financial position and show how it may be relating to other accounts over time.
| Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
| Timeline |
Cara Common Stock Total Equity Regression Statistics
| Arithmetic Mean | 30,609 | |
| Geometric Mean | 19,931 | |
| Coefficient Of Variation | 66.09 | |
| Mean Deviation | 16,568 | |
| Median | 33,000 | |
| Standard Deviation | 20,230 | |
| Sample Variance | 409.2M | |
| Range | 58K | |
| R-Value | 0.90 | |
| Mean Square Error | 85M | |
| R-Squared | 0.81 | |
| Slope | 4,064 | |
| Total Sum of Squares | 5.7B |
Cara Common Stock Total Equity History
About Cara Therapeutic Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cara Therapeutic income statement, its balance sheet, and the statement of cash flows. Cara Therapeutic investors use historical funamental indicators, such as Cara Therapeutic's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Cara Therapeutic investors may use each financial statement separately, they are all related. The changes in Cara Therapeutic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cara Therapeutic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cara Therapeutic Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cara Therapeutic. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Total Equity | 61 K | 33.2 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| C | Citigroup | |
| CRM | Salesforce | |
| MSFT | Microsoft |
Check out the analysis of Cara Therapeutic Correlation against competitors. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Cara Stock analysis
When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Cara Therapeutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cara Therapeutic. If investors know Cara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cara Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.26) | Revenue Per Share 0.312 | Quarterly Revenue Growth (0.65) | Return On Assets (0.62) | Return On Equity (1.47) |
The market value of Cara Therapeutic is measured differently than its book value, which is the value of Cara that is recorded on the company's balance sheet. Investors also form their own opinion of Cara Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Cara Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cara Therapeutic's market value can be influenced by many factors that don't directly affect Cara Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cara Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.